( said Timothy J. McIntyre president and...)New Phase IV Clinical Study Indicates LidoSite Provides,Rheumatology Patients Superior Pain Relief,Health

In the study more than half the rheumatology physicians surveyed found LidoSite exceeded their expectations with regard to positively impacting their patient's experience. Overall, the majority of physicians in the study were satisfied with the LidoSite Topical System in its ease of use and conformity to standard office practices.

"Our experiences with LidoSite demonstrated how it can effectively address patients' needs who have to deal with the pain of these injections," Liebowitz said. "The nature of the treatments involving multiple injections means we can offer a broader range of solutions for those patients who may not seek treatment because of the severity of the associated pain."

Unlike topical anesthetic creams typically used in today's healthcare settings to address needlestick pain, the LidoSite System delivers numbing medication to the procedure site quickly and effectively after a 10 minute application. Topical anesthetic creams usually take up to an hour for full anesthetic benefit.

"LidoSite significantly minimized the pain I was feeling when I received knee injections of hyaluronic acid," said Richard Besser, a patient enrolled in the study. "I have to get injections every six months to treat my osteoarthritis with the pain often more than I care to experience, but using LidoSite has been a tremendous benefit to me and I'm sure to other arthritic patients."

The American Pain Society (APS) and the American Academy of Pediatrics (AAP) set forth guidelines for adequately addressing acute - or short-lived - pain. These guidelines, which apply to the treatment of children and adults, call for healthcare practitioners to eliminate or reduce pain caused by medical treatments whene
'"/>